Program Overview The goal of this course module is to help clinicians and other service providers understand the local and regional picture of HCV, understand HCV screening recommendations, current treatment options, the diagnosis, how to treat HCV patients, and specific issues with vulnerable populations especially people who use drugs and as it relates to the […]
Fatty Liver Symposium 2022-Join us to get the latest updates and information on treatment options for fatty liver disease. Register now: https://www.eventbrite.com/e/fatty-liver-symposium-registration-388648647567 Agenda 8:30am - 8:40am Welcome-Dina Halegoua-DeMarzio, MD & Maria Lagarde, MD 8:40am - 9:00am What is Non-Alcoholic Fatty Liver Disease (NAFLD)? Dina Halegoua-DeMarzio, MD 9:00am - 9:20am Evaluation of Non-Alcoholic Fatty […]
In collaboration with the National Harm Reduction Coalition, the CLA convenes monthly virtual HCV Provider Networking meetings with enduring education, networking and actionable information. The HCV Provider Network reaches clinicians to educate on the importance of harm reduction services and as it relates to hepatitis C prevention and actively engages them to become advocates to […]
Register now: https://cvent.me/1lQgdz The CLA currently provides expertise and guidance to statewide stakeholders, including departments of health, to address the intersection of viral hepatitis and the opioid epidemic through coalition building, educational programs, trainings, advocacy initiatives and elimination planning. We continue to build state coalitions by identifying opportunities to convene and collaborate. Through our […]